Rapid growth in the monoclonal antibodies market has been made possible by technological advances in recombinant monoclonal technologies, showcased by antibody technology experts such as ModiQuest Research. ModiQuest Research will attend BioSpain 2012 (19-21 September, Bilbao, Spain). ModiQuest Sales and Marketing Manager Raymond Egging will be on hand to discuss how their technologies and specialist reagents have enabled research and development of new antibody treatments, plus diagnostics, across a range of therapy areas including autoimmune disease and cancer.
We’re looking forward to meeting people in antibody treatments and diagnostics. It is always mutually beneficial to share knowledge gained with others working in the field of antibody development. At ModiQuest Research we develop antibody-related solutions for even the most intractable targets, so we have a great deal of experience solving the challenges of this growing area of drug development. There is also a great deal of interest in our suite of specialist services and products to support rheumatoid arthritis and other immune disease related research.”
Raymond Egging will be on hand to discuss today’s challenges of antibody development and production at ModiQuest’s exhibition booth B39a. ModiQuest and ModiQuest Research will also be participating in the partnering event of BioSpain 2012. Looking forward to meeting you at BioSpain!